Barclays Upgrades Sotera Health (SHC) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SHC Hot Sheet
Price: $16.37 +2.12%
Rating Summary:
11 Buy, 1 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 28 | New: 13
Rating Summary:
11 Buy, 1 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 28 | New: 13
Join SI Premium – FREE
Barclays analyst Luke Sergott upgraded Sotera Health (NASDAQ: SHC) from Underweight to Overweight with a price target of $22.00 (from $6.00).
For an analyst ratings summary and ratings history on Sotera Health click here. For more ratings news on Sotera Health click here.
Shares of Sotera Health closed at $8.64 yesterday.
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform
- Sotera Health (SHC) PT Lowered to $20 at Barclays
- Stanley Black & Decker (SWK) PT Raised to $135 at Jefferies
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
